Search Within

Jonathan Villena-Vargas

Formats
  1. Journal Article (12)
  2. Meeting Abstract (9)
Groups
  1. Surgery (21)
  2. Sloan Kettering Institute Postdocs (12)
  3. Department of Medicine (11)
  4. Center for Hematologic Malignancies (10)
  5. GSK Faculty (10)
  6. Hematologic Malignancies Research (10)

More Groups

People
  1. Prasad Adusumilli (21)
  2. David Jones (11)
  3. Michel Sadelain (10)
  4. Aurore Morello (8)
  5. Leonid Cherkassky (8)
  6. Camelia Sima (6)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (1)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (7)
  2. Annals of Surgical Oncology (2)
  3. Clinical Cancer Research (2)
  4. American Journal of Surgical Pathology (1)
  5. Cancer Immunology Research (1)
  6. Chest (1)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Association for Cancer Research (3)
  3. Springer (2)
  4. American Association for the Advancement of Science (1)
  5. American College of Chest Physicians (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor budding correlates with the protumor immune microenvironment and is an independent prognostic factor for recurrence of stage I lung adenocarcinoma
    Journal Article

    Kadota, K.; Yeh, Y. C.; Villena-Vargas, J.; Cherkassky, L.; Drill, E. N.; Sima, C. S.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Chest (2015)

    Fulltext@MSK | Save
  • Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma
    Journal Article

    Kadota, K.; Buitrago, D.; Lee, M. C.; Villena-Vargas, J.; Sima, C. S.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Lung Cancer (2015)

    Fulltext@MSK | Save
  • Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma
    Journal Article

    Kadota, K.; Villena-Vargas, J.; Nitadori, J. I.; Sima, C. S.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Cisplatin-induced antitumor immunomodulation: A review of preclinical and clinical evidence
    Journal Article

    De Biasi, A. R.; Villena-Vargas, J.; Adusumilli, P. S.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
    Journal Article

    Adusumilli, P. S.; Cherkassky, L.; Villena-Vargas, J.; Colovos, C.; Servais, E.; Plotkin, J.; Jones, D. R.; Sadelain, M.
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Mesothelin-targeted T Cells Gene-Engineered with 4-1BB Costimulation Overcome Tumor-Mediated Immunoinhibition and Eradicate Established Solid Tumors
    Meeting Abstract

    Cherkassky, L.; Villena-Vargas, J.; Morello, A.; Rusch, V. W.; Sadelain, M.; Adusumilli, P.
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease
    Journal Article

    Kadota, K.; Villena-Vargas, J.; Yoshizawa, A.; Motoi, N.; Sima, C. S.; Riely, G. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save
  • Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma
    Journal Article

    Kachala, S. S.; Bograd, A. J.; Villena-Vargas, J.; Suzuki, K.; Servais, E. L.; Kadota, K.; Chou, J.; Sima, C. S.; Vertes, E.; Rusch, V. W.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies
    Meeting Abstract

    Villena-Vargas, J.; Rodriguez, L. A.; Moroz, M.; Cherkassky, L.; Rusch, V. W.; Sadelain, M.; Ponomarev, V.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Critical role of CD28 costimulation in tumor-targeted T-cell therapy clinical trial for pleural malignancies
    Meeting Abstract

    Villena-Vargas, J.; Cherkassky, L.; Colovos, C.; Servais, E.; Rodriguez, L. A.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save